Convergence Investment Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $313K | Sell |
11,140
-395
| -3% | -$10.5K | 0.05% | 218 |
|
|
2025
Q4 | $287K | Sell |
11,535
-242
| -2% | -$6.1K | 0.06% | 224 |
|
|
2025
Q3 | $300K | Buy |
11,777
+477
| +4% | +$11.8K | 0.07% | 221 |
|
|
2025
Q2 | $274K | Sell |
11,300
-48,188
| -81% | -$1.12M | 0.07% | 211 |
|
|
2025
Q1 | $1.51M | Sell |
59,488
-47,925
| -45% | -$1.25M | 0.42% | 74 |
|
|
2024
Q4 | $2.85M | Buy |
107,413
+93,533
| +674% | +$2.54M | 0.64% | 37 |
|
|
2024
Q3 | $402K | Sell |
13,880
-5,254
| -27% | -$153K | 0.11% | 185 |
|
|
2024
Q2 | $535K | Buy |
19,134
+6,451
| +51% | +$178K | 0.16% | 180 |
|
|
2024
Q1 | $352K | Sell |
12,683
-1,663
| -12% | -$46.1K | 0.13% | 180 |
|
|
2023
Q4 | $413K | Sell |
14,346
-7,781
| -35% | -$235K | 0.22% | 103 |
|
|
2023
Q3 | $734K | Buy |
22,127
+4,656
| +27% | +$165K | 0.43% | 79 |
|
|
2023
Q2 | $641K | Buy |
17,471
+5,414
| +45% | +$211K | 0.37% | 83 |
|
|
2023
Q1 | $492K | Sell |
12,057
-206
| -2% | -$8.9K | 0.29% | 91 |
|
|
2022
Q4 | $628K | Sell |
12,263
-6,673
| -35% | -$320K | 0.37% | 77 |
|
|
2022
Q3 | $829K | Sell |
18,936
-49,594
| -72% | -$2.41M | 0.54% | 66 |
|
|
2022
Q2 | $3.59M | Buy |
68,530
+1,743
| +3% | +$88.8K | 2.17% | 4 |
|
|
2022
Q1 | $3.46M | Buy |
66,787
+2,742
| +4% | +$142K | 1.78% | 5 |
|
|
2021
Q4 | $3.78M | Sell |
64,045
-2,475
| -4% | -$123K | 1.93% | 3 |
|
|
2021
Q3 | $2.86M | Buy |
66,520
+4,496
| +7% | +$199K | 1.54% | 7 |
|
|
2021
Q2 | $2.43M | Buy |
62,024
+12,694
| +26% | +$494K | 1.04% | 21 |
|
|
2021
Q1 | $1.79M | Sell |
49,330
-7,436
| -13% | -$264K | 0.82% | 42 |
|
|
2020
Q4 | $2.09M | Sell |
56,766
-23,751
| -29% | -$871K | 1.05% | 24 |
|
|
2020
Q3 | $2.8M | Buy |
80,517
+65,176
| +425% | +$2.29M | 0.98% | 21 |
|
|
2020
Q2 | $476K | Sell |
15,341
-57,522
| -79% | -$1.95M | 0.16% | 175 |
|
|
2020
Q1 | $2.26M | Sell |
72,863
-59,801
| -45% | -$2.04M | 0.99% | 26 |
|
|
2019
Q4 | $4.93M | Buy |
132,664
+32,501
| +32% | +$1.16M | 1.4% | 9 |
|
|
2019
Q3 | $3.41M | Sell |
100,163
-27,491
| -22% | -$1,000K | 0.95% | 25 |
|
|
2019
Q2 | $5.25M | Sell |
127,654
-66,324
| -34% | -$2.63M | 1.27% | 10 |
|
|
2019
Q1 | $7.82M | Sell |
193,978
-8,958
| -4% | -$359K | 1.71% | 4 |
|
|
2018
Q4 | $8.4M | Sell |
202,936
-12,709
| -6% | -$528K | 1.93% | 3 |
|
|
2018
Q3 | $9.02M | Sell |
215,645
-127,191
| -37% | -$4.9M | 1.84% | 1 |
|
|
2018
Q2 | $11.8M | Buy |
342,836
+24,736
| +8% | +$845K | 1.65% | 2 |
|
|
2018
Q1 | $10.7M | Buy |
318,100
+172,591
| +119% | +$5.93M | 1.4% | 4 |
|
|
2017
Q4 | $5M | Sell |
145,509
-7,757
| -5% | -$264K | 0.67% | 23 |
|
|
2017
Q3 | $5.19M | Sell |
153,266
-126,230
| -45% | -$4.06M | 0.74% | 21 |
|
|
2017
Q2 | $8.91M | Buy |
279,496
+7,127
| +3% | +$225K | 1.3% | 3 |
|
|
2017
Q1 | $8.84M | Buy |
272,369
+50,346
| +23% | +$1.59M | 1.24% | 5 |
|
|
2016
Q4 | $6.84M | Sell |
222,023
-106,599
| -32% | -$3.25M | 0.94% | 8 |
|
|
2016
Q3 | $10.6M | Buy |
328,622
+190,239
| +137% | +$6.36M | 1.56% | 2 |
|
|
2016
Q2 | $4.62M | Sell |
138,383
-2,953
| -2% | -$94.2K | 0.64% | 31 |
|
|
2016
Q1 | $3.98M | Buy |
141,336
+719
| +0.5% | +$20.5K | 0.47% | 73 |
|
|
2015
Q4 | $4.31M | Sell |
140,617
-194,040
| -58% | -$6.1M | 0.48% | 70 |
|
|
2015
Q3 | $9.97M | Buy |
334,657
+197,223
| +144% | +$6.32M | 1.14% | 9 |
|
|
2015
Q2 | $4.37M | Buy |
137,434
+4,235
| +3% | +$138K | 0.43% | 74 |
|
|
2015
Q1 | $4.4M | Buy |
133,199
+9,952
| +8% | +$316K | 0.61% | 30 |
|
|
2014
Q4 | $3.64M | Sell |
123,247
-114,093
| -48% | -$3.27M | 0.49% | 52 |
|
|
2014
Q3 | $6.66M | Sell |
237,340
-149,997
| -39% | -$4.21M | 0.91% | 12 |
|
|
2014
Q2 | $10.9M | Buy |
387,337
+24,813
| +7% | +$707K | 1.44% | 7 |
|
|
2014
Q1 | $11M | Buy |
362,524
+82,768
| +30% | +$2.47M | 1.68% | 6 |
|
|
2013
Q4 | $8.13M | Buy |
279,756
+14,100
| +5% | +$410K | 1.32% | 9 |
|
|
2013
Q3 | $7.24M | Buy |
265,656
+63,536
| +31% | +$1.73M | 1.53% | 8 |
|
|
2013
Q2 | $5.37M | Buy |
+202,120
| New | +$5.58M | 1.39% | 8 |
|
Other funds holding PFE
VCM
VPM
Convergence Investment Partners's PFE Position: Q1 2026 in Review
Convergence Investment Partners reduced its Pfizer (PFE) stake by 3.4% in Q1 2026, selling an estimated $10.5K and leaving 11,140 shares worth $313K. The position accounts for 0.05% of the portfolio, ranked #218.
Convergence Investment Partners first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.8M in Q2 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Convergence Investment Partners held 11,140 shares of Pfizer worth $313K as of Q1 2026.
- Convergence Investment Partners sold 395 Pfizer shares in Q1 2026, an estimated $10.5K.
- Pfizer made up 0.05% of Convergence Investment Partners's portfolio in Q1 2026, its #218 holding.
- Convergence Investment Partners first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Convergence Investment Partners's Pfizer position peaked at $11.8M in Q2 2018.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Convergence Investment Partners's 13F filing for Q1 2026, filed 7 May 2026.